The motorized device is worn over the legs and part of the upper body, and it helps an individual sit, stand and walk with assistance from a trained companion. ReWalk is for people with paraplegia due to spinal cord injuries at levels T7 to L5 when accompanied by a specially trained caregiver. It is also for people with spinal cord injuries at levels T4 to T6, where the device is limited to use in rehabilitation institutions.
ReWalk was manufactured by Argo Medical Technologies, and the company is required to complete a post-market clinical study, according to the FDA.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
